Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
33
ASND Quote, Financials, Valuation and Earnings
Last price:
$177.09
Seasonality move
:
11.4%
Day range:
$171.10 - $176.23
52-week range:
$111.09 - $183.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
26.12x
P/B ratio:
--
Volume:
426.4K
Avg. volume:
427.2K
1-year change:
24.57%
Market cap:
$10.6B
Revenue:
$393.6M
EPS (TTM):
-$6.29
Earnings Data
Next earnings date for ASND
Sep 03
2025
Most recent earnings per share
-$1.66
Beat by $0.05
(May 1/2025)
Consensus Estimate
-$1.71
(May 1/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ASND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $212.9M | -- | -- | -$0.70 | -- |
| 09/03/2025 | Q2 | $168.1M | -- | -- | -$1.52 | -- |
| 05/01/2025 | Q1 | $107.9M | $106.2M | -$1.66 | -$1.71 | $0.05 |
| 02/12/2025 | Q4 | $123.2M | $185.4M | -$0.68 | -$0.96 | $0.28 |
| 11/14/2024 | Q3 | $76.5M | $63.6M | -$1.89 | -$1.57 | -$0.32 |
| 09/03/2024 | Q2 | $94.2M | $38.8M | -$2.06 | -$1.40 | -$0.65 |
| 05/02/2024 | Q1 | $85.6M | $104.2M | -$2.50 | -$1.52 | -$0.98 |
| 02/07/2024 | Q4 | $92.1M | $148.3M | -$1.66 | -$1.90 | $0.24 |
| 11/07/2023 | Q3 | -- | -- | -$3.14 | -$2.37 | -$0.76 |
| 09/05/2023 | Q2 | -- | -- | -$2.36 | -$2.80 | $0.45 |
| 04/27/2023 | Q1 | -- | -- | -$2.13 | -$2.89 | $0.77 |
| 02/16/2023 | Q4 | -- | -- | -$3.78 | -$2.77 | -$1.02 |
| 11/02/2022 | Q3 | -- | -- | -$3.05 | -$2.52 | -$0.53 |
| 08/10/2022 | Q2 | -- | -- | -$1.56 | -$2.28 | $0.73 |
| 05/11/2022 | Q1 | -- | -- | -$2.48 | -$2.15 | -$0.33 |
| 03/02/2022 | Q4 | -- | -- | -$2.14 | -$2.59 | $0.46 |
| 11/10/2021 | Q3 | -- | -- | -- | -$2.66 | -- |
| 08/25/2021 | Q2 | -- | -- | -$3.01 | -$2.64 | -$0.37 |
| 05/27/2021 | Q1 | -- | -- | -$1.41 | -$2.27 | $0.86 |
| 03/10/2021 | Q4 | -- | -- | -$3.15 | -$1.88 | -$1.27 |
| 11/11/2020 | Q3 | -- | -- | -$2.70 | -$1.87 | -$0.83 |
| 08/27/2020 | Q2 | -- | -- | -$2.17 | -$1.60 | -$0.57 |
| 05/19/2020 | Q1 | -- | -- | -$1.46 | -$1.40 | -$0.05 |
| 12/31/2019 | Q4 | -- | -- | -$1.88 | -$1.32 | -$0.56 |
| 11/18/2019 | Q3 | -- | -- | -$0.59 | -$1.28 | $0.69 |
| 08/28/2019 | Q2 | -- | -- | -- | -$1.33 | -- |
| 04/03/2019 | Q1 | -- | -- | -- | -$1.14 | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -$1.13 | -- |
| 11/28/2018 | Q3 | -- | -- | -- | -$1.20 | -- |
| 08/29/2018 | Q2 | -- | -- | -- | -$0.99 | -- |
| 05/30/2018 | Q1 | -- | -- | -- | -- | -- |
| 03/28/2018 | Q4 | -- | -- | -- | -- | -- |
| 11/16/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/18/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/31/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -- | -- | -- |
Ascendis Pharma AS Earnings Questions
-
How Much did Ascendis Pharma AS Generate in Revenue Last Quarter?
Ascendis Pharma AS reported $106.2M worth of top line sales in its most recent quarter.
-
Did Ascendis Pharma AS Beat Earnings Last Quarter?
Ascendis Pharma AS announced earnings per share of -$1.66 which represents a beat of analyst forecast a -$1.71 per share.
-
Is Ascendis Pharma AS Profitable?
Ascendis Pharma AS reported $87.8M that represents $1.46 per share over the last quarter.
-
What is the Analyst Consensus for Ascendis Pharma AS EPS Next Year?
Ascendis Pharma AS's earnings are forecast to decrease from -$7.07 per share to -$6.78 per share next year representing a decrease of -41.14%.
-
When is Ascendis Pharma AS's Earnings Date?
Ascendis Pharma AS's next earnings date is September 3, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
